IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10472336 B1

PDFFull Text
Date of Patent:
Nov. 12, 2019

Filed:

Sep. 22, 2016

Modulators of indoleamine 2,3-dioxygenase

Applicant:

Glaxosmithkline Intellectual Property (No.2) Limited, Brentford, Middlesex, GB;

Inventors:

Pek Yoke Chong, Research Triangle Park, NC (US);

Martha Alicia De La Rosa, Research Triangle Park, NC (US);

Hamilton D. Dickson, Research Triangle Park, NC (US);

Wieslaw Mieczyslaw Kazmierski, Research Triangle Park, NC (US);

Vicente Samano, Research Triangle Park, NC (US);

Vincent Wing-Fai Tai, Research Triangle Park, NC (US);

Assignee:

GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED, Brentford, Middlesex, GB;

Attorneys:

Robert H. Brink

Kathryn A. Lutomski

Edward R. Gimmi

Primary Examiner:

Joseph R Kosack

Int. Cl.
CPC ...
C07D 285/08 (2006.01); C07D 263/58 (2006.01); C07D 213/74 (2006.01); C07D 309/14 (2006.01); C07D 333/20 (2006.01); C07D 235/30 (2006.01); C07D 239/42 (2006.01); C07D 241/20 (2006.01); C07D 253/06 (2006.01); C07D 263/48 (2006.01); C07D 277/82 (2006.01); C07D 285/00 (2006.01); C07D 307/66 (2006.01); C07C 229/42 (2006.01); C07D 239/47 (2006.01); C07D 249/14 (2006.01); C07D 277/28 (2006.01); C07D 277/42 (2006.01); C07D 277/593 (2006.01); C07D 285/135 (2006.01); C07D 307/52 (2006.01);
U.S. Cl.
CPC ...
C07D 263/58 (2013.01); C07C 229/42 (2013.01); C07D 213/74 (2013.01); C07D 235/30 (2013.01); C07D 239/42 (2013.01); C07D 239/47 (2013.01); C07D 241/20 (2013.01); C07D 249/14 (2013.01); C07D 253/06 (2013.01); C07D 263/48 (2013.01); C07D 277/28 (2013.01); C07D 277/42 (2013.01); C07D 277/593 (2013.01); C07D 277/82 (2013.01); C07D 285/00 (2013.01); C07D 285/08 (2013.01); C07D 285/135 (2013.01); C07D 307/52 (2013.01); C07D 307/66 (2013.01); C07D 309/14 (2013.01); C07D 333/20 (2013.01); C07C 2601/14 (2017.05); C07C 2601/16 (2017.05);
Abstract

Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of HIV; including the prevention of the progression of AIDS and general immunosuppression.

Find Patent Forward Citations

Loading…